Anika Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Anika Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2019 to Q3 2024.
  • Anika Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $27.2M, a 6.35% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $27.2M -$1.85M -6.35% Sep 30, 2024 10-Q 2024-11-04
Q2 2024 $27.8M -$1.87M -6.3% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $28.2M -$1.99M -6.61% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $28.8M -$1.93M -6.28% Dec 31, 2023 10-Q 2024-11-04
Q3 2023 $29.1M -$1.93M -6.24% Sep 30, 2023 10-Q 2023-11-03
Q2 2023 $29.6M -$1.98M -6.25% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $30.2M +$9.66M +47.1% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $30.7M +$9.74M +46.5% Dec 31, 2022 10-K 2024-03-15
Q3 2022 $31M +$9.59M +44.8% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $31.6M +$9.76M +44.7% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $20.5M -$1.81M -8.1% Mar 31, 2022 10-Q 2022-05-06
Q4 2021 $21M -$1.66M -7.35% Dec 31, 2021 10-K 2023-03-16
Q3 2021 $21.4M -$1.5M -6.56% Sep 30, 2021 10-Q 2021-11-05
Q2 2021 $21.8M -$1.35M -5.81% Jun 30, 2021 10-Q 2021-08-06
Q1 2021 $22.3M -$1.2M -5.11% Mar 31, 2021 10-Q 2021-05-07
Q4 2020 $22.6M -$245K -1.07% Dec 31, 2020 10-K 2022-03-11
Q3 2020 $22.9M -$184K -0.8% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $23.2M -$299K -1.27% Jun 30, 2020 10-Q 2020-08-07
Q1 2020 $23.5M -$220K -0.93% Mar 31, 2020 10-Q 2020-05-22
Q4 2019 $22.9M Dec 31, 2019 10-K/A 2021-04-26
Q3 2019 $23.1M Sep 30, 2019 10-Q 2019-10-28
Q2 2019 $23.5M Jun 30, 2019 10-Q 2019-07-26
Q1 2019 $23.7M Mar 31, 2019 10-Q 2019-05-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.